The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
外核苷酸酶 CD39 可识别肿瘤反应性 CD8+ T 细胞,这些细胞可预测人类肺癌中免疫检查点阻断疗法的疗效。
期刊:Immunity
影响因子:25.5
doi:10.1016/j.immuni.2022.12.001
Andrew Chow,Fathema Z Uddin,Michael Liu,Anton Dobrin,Barzin Y Nabet,Levi Mangarin,Yonit Lavin,Hira Rizvi,Sam E Tischfield,Alvaro Quintanal-Villalonga,Joseph M Chan,Nisargbhai Shah,Viola Allaj,Parvathy Manoj,Marissa Mattar,Maximiliano Meneses,Rebecca Landau,Mariana Ward,Amanda Kulick,Charlene Kwong,Matthew Wierzbicki,Jessica Yavner,Jacklynn Egger,Shweta S Chavan,Abigail Farillas,Aliya Holland,Harsha Sridhar,Metamia Ciampricotti,Daniel Hirschhorn,Xiangnan Guan,Allison L Richards,Glenn Heller,Jorge Mansilla-Soto,Michel Sadelain,Christopher A Klebanoff,Matthew D Hellmann,Triparna Sen,Elisa de Stanchina,Jedd D Wolchok,Taha Merghoub,Charles M Rudin
肺癌
Human
细胞生物学
肿瘤
免疫/内分泌
CD3
CD8
CD39
Checkpoint